跳至主要内容
临床试验/CTRI/2013/04/003542
CTRI/2013/04/003542进行中(未招募)未知

A Cross-sectional, Multicentre, Out â?? patient clinic based study to determine the prevalence of recurrent spontaneous miscarriages among Indian women with a history of at least one miscarriage

Abbott India Limited0 个研究点目标入组 750 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
750

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Female patients aged between 18 to 45 years, both inclusive
  • 2.History of at least one spontaneous miscarriage of <= 20 weeks gestation
  • 3.Willing to provide written Patient Authorization.

排除标准

  • 1.Female patients unable to provide written authorization
  • 2.Any condition that in the opinion of the investigator, does not justify the patients inclusion in the study

研究者

相似试验

已完成
不适用
Survey to understand the demographics, diagnosis, clinical presentation in patients with acid peptic disease
CTRI/2021/02/031271Dr Reddys Laboratories Ltd3,739
招募中
不适用
To aim of this study is to determine the prevalence of Non-Alcoholic Fatty Liver Disease and Thyroid Dysfunction in Patients with Metabolic Syndrome.
CTRI/2016/09/007270Abbott India Limited400
进行中(未招募)
不适用
A multicenter, randomized, parallel patients’ group, comparative clinical trial for the assessement of efficacy and safety of Pelethrocin®/HELP 500 mg (generic diosmin & hesperidin MPFF) versus Daflon®/Servier 500 mg (original diosmin & hesperidin MPFF) in the treatment of chronic venous insufficiency patients (a therapeutic equivalence trial).Chronic Venous InsufficiencyMedDRA version: 9.1Level: LLTClassification code 10066682Term: Chronic venous insufficiency
EUCTR2007-001947-23-GRHELP Pharmaceuticals S.A.
暂停
不适用
Evaluating the effects of high and low oxygen therapy compared to standard oxygen therapy in patients undergoing major surgery under general anaesthesiaHyperoxia, hyperoxaemiaMajor non-cardiac surgerySurgical site infectionPostoperative complicationsAnaesthesiology - Anaesthetics
ACTRN12619000115134Medical Research Institute of New Zealand2,640
进行中(未招募)
不适用
A Multicenter, Randomized, Comparative, Patient-blinded Study to Evaluate the Safety and Efficacy of G-CSF Alone Versus AMD3100 (240 µg/kg) Added to a G-CSF Mobilization Regimen in Adult Patients with Non-Hodgkin’s Lymphoma (NHL), Hodgkin’s Disease (HD) or Multiple Myeloma (MM) Who Have Previously Failed Stem Cell Collections.
EUCTR2006-004247-29-DEGenzyme Europe BV